27 related articles for article (PubMed ID: 20038980)
1. Determinants of generic drug substitution in Switzerland.
Decollogny A; Eggli Y; Halfon P; Lufkin TM
BMC Health Serv Res; 2011 Jan; 11():17. PubMed ID: 21269426
[TBL] [Abstract][Full Text] [Related]
2. Generic and therapeutic substitutions in the UK: are they a good thing?
Duerden MG; Hughes DA
Br J Clin Pharmacol; 2010 Sep; 70(3):335-41. PubMed ID: 20716231
[TBL] [Abstract][Full Text] [Related]
3. CMS Consideration of Rebate Overhaul Elicits Strong Opinions Both Pro and Con.
Barlas S
P T; 2018 Apr; 43(4):193. PubMed ID: 29622937
[TBL] [Abstract][Full Text] [Related]
4. Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014-2019.
Gradl G; Werning J; Enners S; Kieble M; Schulz M
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356753
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons.
Gradl G; Krieg EM; Schulz M
Pharm Pract (Granada); 2016; 14(3):786. PubMed ID: 27785166
[TBL] [Abstract][Full Text] [Related]
6. Preferred supplier contracts in post-patent prescription drug markets.
Blankart CR; Stargardt T
Health Care Manag Sci; 2017 Sep; 20(3):419-432. PubMed ID: 26899436
[TBL] [Abstract][Full Text] [Related]
7. Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review.
Hermanowski TR; Drozdowska AK; Kowalczyk M
Int J Integr Care; 2015; 15():e036. PubMed ID: 26528099
[TBL] [Abstract][Full Text] [Related]
8. [Intensified collaborative care: a model of successful acting in ambulatory cardiology].
Smetak N
Inn Med (Heidelb); 2022 Sep; 63(9):930-938. PubMed ID: 35943538
[TBL] [Abstract][Full Text] [Related]
9. [General practitioner-centered care: a model with potential for improvement?].
Grebe IG; Hector R
Inn Med (Heidelb); 2022 Sep; 63(9):939-946. PubMed ID: 35925128
[TBL] [Abstract][Full Text] [Related]
10. The effect of introducing rebate contracts to promote generic drug substitution, on doctors' prescribing practices.
Hoffmann F; Glaeske G; Pfannkuche MS
Dtsch Arztebl Int; 2009 Nov; 106(48):783-8. PubMed ID: 20038980
[TBL] [Abstract][Full Text] [Related]
11. [Regional differences in the use of 'no substitution' in the elderly after introduction of rebate contracts].
Hoffmann F; Windt R; Glaeske G
Gesundheitswesen; 2011 Jul; 73(7):438-42. PubMed ID: 20544592
[TBL] [Abstract][Full Text] [Related]
12. [Implementation of "aut idem" before and after introduction of rebate contracts].
Hoffmann F; Windt R; Glaeske G
Dtsch Med Wochenschr; 2010 Apr; 135(15):739-44. PubMed ID: 20373270
[TBL] [Abstract][Full Text] [Related]
13. [Prescription of generic drugs to privately insured persons].
Wild F
Versicherungsmedizin; 2012 Dec; 64(4):190-2. PubMed ID: 23236709
[TBL] [Abstract][Full Text] [Related]
14. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
Bhargava V; Greg ME; Shields MC
J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829
[TBL] [Abstract][Full Text] [Related]
15. Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending.
Bekelman JE; Gupta A; Fishman E; Debono D; Fisch MJ; Liu Y; Sylwestrzak G; Barron J; Navathe AS
J Clin Oncol; 2020 Dec; 38(34):4055-4063. PubMed ID: 33021865
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
